Press Releases


New Study: Medicare could save seniors billions by fixing Part D incentives

WASHINGTON, DC and BESSEMER, AL—Plan sponsors and PBMs who manage prescription drug benefits under Medicare Part D are shifting costs and risks to America’s seniors and taxpayers by artificially inflating prescription drug costs at the pharmacy counter, according to a groundbreaking new study released today.

President Biden’s new "Test to Treat" initiative recognizes pharmacies, but barriers should be removed

WASHINGTON, D.C.—The American Pharmacists Association (APhA) made the following statement today in response to the State of the Union address on Tuesday, March 1.

APhA2022 General Sessions topics and speakers announced

Sessions to focus on better care for patients and patient care through innovation

WASHINGTON, DC—APhA2022, the American Pharmacists Association’s 2022 Annual Meeting & Exposition, has announced the speakers and topics for its two general sessions. APhA2022 will be an in-person event held March 18–21, 2022, at the Henry B. González Convention Center in San Antonio, TX.

APhA expresses disappointment at failed Federal Trade Commission vote to study PBMs’ anticompetitive business practices

APhA urges the Federal Trade Commission (FTC) to reach a consensus to not only study, but fix the broken PBM marketplace

WASHINGTON, D.C.—The American Pharmacists Association (APhA) issued the following statement in response to the FTC’s stalemate 2-2 vote today, which would have supported study of the competitive impact of contractual provisions, reimbursement adjustments, and other PBM practices affecting drug prices, including those practices that may disadvantage independent or specialty pharmacies.

APhA congratulates Robert Califf, MD, on confirmation as FDA Commissioner

WASHINGTON, D.C.—The American Pharmacists Association (APhA) issued the following statement to congratulate Robert Califf, MD, on his confirmation to serve once again as commissioner of FDA. APhA looks forward to working with both Califf and the FDA to ensure the safety, efficacy, and security of medications for our nation’s pharmacy patients.